AMOON FUND

amoon-fund-logo

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the worldโ€™s most life-threatening conditions and those providing solutions for global healthcareโ€™s biggest cost drivers.

#SimilarOrganizations #People #Financial #Event #More

AMOON FUND

Social Links:

Industry:
Biotechnology Health Care Venture Capital

Founded:
2016-01-01

Status:
Active

Contact:
+972.54.807.7287

Technology used in webpage:
Domain Not Resolving Amazon ReCAPTCHA Cloudflare Hosting Cloudflare JS CDN JS Facebook Sharer WordPress 6.4 IIS 10 Amazon S3


Similar Organizations

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

mrl-ventures-fund-logo

MRL Ventures Fund

MRL Ventures is Merckโ€™s independent early-stage therapeutics venture capital fund.

oncohost-logo

OncoHost

OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.

Current Employees Featured

yair-schindel_image

Yair Schindel
Yair Schindel Managing Partner @ aMoon Fund
Managing Partner
2016-09-01

tomer-berkovitz_image

Tomer Berkovitz
Tomer Berkovitz Managing Partner @ aMoon Fund
Managing Partner
2018-02-01

roy-wiesner_image

Roy Wiesner
Roy Wiesner Managing Director @ aMoon Fund
Managing Director
2018-03-01

michal-goren-miller_image

Michal Goren Miller
Michal Goren Miller Chief Legal Counsel & Chief Compliance Officer @ aMoon Fund
Chief Legal Counsel & Chief Compliance Officer
2017-03-01

marius-nacht_image

Marius Nacht
Marius Nacht Founder & Anchor Investor @ aMoon Fund
Founder & Anchor Investor
2017-01-01

not_available_image

Gur Roshwalb
Gur Roshwalb Managing Director @ aMoon Fund
Managing Director
2019-01-01

moshe-mor_image

Moshe Mor
Moshe Mor General Partner @ aMoon Fund
General Partner
2020-01-01

Founder


marius-nacht_image

Marius Nacht

yair-schindel_image

Yair Schindel

Investments List

Date Company Article Money raised
2024-05-21 AltruBio aMoon Fund investment in Series B - AltruBio 225 M USD
2023-11-08 Eleos Health aMoon Fund investment in Series B - Eleos Health 40 M USD
2023-09-06 Ibex Medical Analytics aMoon Fund investment in Series C - Ibex Medical Analytics 55 M USD
2023-08-29 Better Life Partners aMoon Fund investment in Series B - Better Life Partners 26.5 M USD
2022-11-30 Nectin Therapeutics aMoon Fund investment in Series A - Nectin Therapeutics 25 M USD
2022-11-09 Ibex Medical Analytics aMoon Fund investment in Debt Financing - Ibex Medical Analytics 10 M USD
2022-09-20 Lyfegen aMoon Fund investment in Series A - Lyfegen 8 M USD
2022-08-29 Theranica aMoon Fund investment in Series C - Theranica 45 M USD
2022-05-31 Ultima Genomics aMoon Fund investment in Venture Round - Ultima Genomics 600 M USD
2022-04-05 Eleos Health aMoon Fund investment in Series A - Eleos Health 20 M USD

Newest Events participated

mixiii-biomed-2018_event_image Participated in Mixiii Biomed 2018 on 2018-05-15 as sponsor

More informations about "aMoon Fund"

aMoon - We Believe

A global fund based in Israel with over $1.3B AUM, aMoon leverages the pioneering scientific research, raw talent and do-the-impossible culture of the Startup Nation. As Israelโ€™s largest HealthTech VC fund, we partner with โ€ฆSee details»

aMoon - Portfolio

We partner with exceptional entrepreneurs who harness groundbreaking science and technology to transform healthcare. Through aMoon Velocity and aMoon Growth, we invest in early and late-stage companies pursuing disruptive, โ€ฆSee details»

aMoon Fund - Crunchbase Investor Profile & Investments

AMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology โ€ฆSee details»

aMoon Fund - LinkedIn

AMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israelโ€™s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness ...See details»

aMoon Fund - Investments, Portfolio & Company Exits - Crunchbase

AMoon Fund 's most notable exits include Seer, ... Which industries has this organization had the most exits in? Show . Seer Seer is a biotechnology company that offers tools and solutions โ€ฆSee details»

Mission โ€“ impact - impact.amoon.fund

AMoon was founded in 2017 to seize on the rapid convergence of healthcare and technology with the mission to Accelerate Cure. We have been built from the ground-up with this goal in mind. โ€ฆSee details»

aMoon 2020 Impact Report - impact.amoon.fund

AMoon Impact Report 2020 8 OUR IMPACT Harvesting a deep blue ocean of innovation to revolutionize healthcare. First, because it is part of our DNA. What drives us as individuals and โ€ฆSee details»

Our Impact โ€“ impact - impact.amoon.fund

Through Alpha, we tap aMoonโ€™s global network and talent capabilities to offer our portfolio companies tailored access to global capital markets, leading research and scientific โ€ฆSee details»

aMoon Fund - Funding, Financials, Valuation & Investors

Sep 25, 2018 aMoon Fund has raised 1 round. This was a Series A round raised on Sep 25, 2018 . aMoon Fund has raised a total of $1.2B across 3 funds, their latest being aMoon โ€ฆSee details»

aMoon Growth - aMoon Accelerating Cure

AMoon Growth. Our Growth Fund looks for mission-driven companies led by exceptional management teams that have the potential to accelerate cure and reach significant value โ€ฆSee details»

Credit Suisse to pump $250 million into Israeli health tech venture ...

May 16, 2018 aMoon Partners, an Israeli life-sciences venture capital firm that is backed by Israeli billionaire Marius Nacht, said last month that it raised $200 million for its second and โ€ฆSee details»

aMoon Fund - Private Equity List

AMoon was founded in 2017 to seize on the rapid convergence of healthcare and technology with the mission to Accelerate Cure. We have been built from the ground-up with this goal in mind. โ€ฆSee details»

impact โ€“ aMoon impact reports

AMoon 2020 Impact Report . Accelerating Cure . We are excited to share the first in what we expect will be an annual series of aMoon Impact reports. The purpose of this annual impact โ€ฆSee details»

aMoon - What we look for in companies - aMoon Accelerating Cure

Team and trust are key ingredients, but no company (or fund) is complete without a vision. At aMoon, we are out to change the world of healthcare, leverage new disruptive technologies, โ€ฆSee details»

List of top aMoon Fund Portfolio Companies - Crunchbase

Mar 2, 2014 aMoon is a leading healthtech & life sciences venture capital firm. This list of organizations invested in by aMoon Fund provides data on their funding history, investment โ€ฆSee details»

aMoon Fund Leads Investment Round - Nectintx

Jul 20, 2020 aMoon Velocity, the early-stage fund of Israelโ€™s largest HealthTech and life sciences venture fund aMoon, ... Integra Holdings is a unique venture organization with a โ€ฆSee details»

aMoon - Team

We are a team of scientists, physicians, entrepreneurs and investors with global experience who have dedicated our lives to science, medicine, technology, and progress. Serial entrepreneurs โ€ฆSee details»

International Pathogen Surveillance Network announces first โ€ฆ

5 days ago The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to improve capacities in pathogen genomic surveillance. โ€ฆSee details»

aMoon - Team - Platform

AMoon Velocity - We are a team of scientists, physicians, entrepreneurs and investors with global experience who have dedicated our lives to science, medicine, technology, and progress.See details»

Jim Weissman - aMoon - amoon.fund

Jim Weissman is a life sciences industry veteran, bringing over 30 years of experience in various roles such as business and corporate development, general management, marketing, mergers โ€ฆSee details»